Diaceutics (DXRX) Competitors

Diaceutics (LON:DXRX) and ANGLE (LON:AGL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their media sentiment, risk, community ranking, analyst recommendations, dividends, institutional ownership, valuation, earnings and profitability.

Is DXRX or AGL more profitable?

Diaceutics has a net margin of -10.90% compared to ANGLE's net margin of -890.91%. Diaceutics' return on equity of -7.15% beat ANGLE's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Diaceutics	-10.90%	-7.15%	-6.06%
ANGLE	-890.91%	-76.01%	-29.89%

Do institutionals and insiders hold more shares of DXRX or AGL?

52.4% of Diaceutics shares are owned by institutional investors. Comparatively, 18.8% of ANGLE shares are owned by institutional investors. 34.3% of Diaceutics shares are owned by company insiders. Comparatively, 16.2% of ANGLE shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Do analysts prefer DXRX or AGL?

Diaceutics presently has a consensus target price of GBX 160, suggesting a potential upside of 31.15%. ANGLE has a consensus target price of GBX 40, suggesting a potential upside of 362.43%. Given ANGLE's higher possible upside, analysts clearly believe ANGLE is more favorable than Diaceutics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Diaceutics	0 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	3.00
ANGLE	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the MarketBeat Community prefer DXRX or AGL?

ANGLE received 168 more outperform votes than Diaceutics when rated by MarketBeat users. However, 88.24% of users gave Diaceutics an outperform vote while only 62.46% of users gave ANGLE an outperform vote.

Company	Underperform	Outperform
Diaceutics	Outperform Votes 15 88.24%	Underperform Votes 2 11.76%
ANGLE	Outperform Votes 183 62.46%	Underperform Votes 110 37.54%

Which has preferable earnings & valuation, DXRX or AGL?

Diaceutics has higher revenue and earnings than ANGLE. Diaceutics is trading at a lower price-to-earnings ratio than ANGLE, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Diaceutics	£26.08M	3.95	-£2.84M	-£3.37	-36.18
ANGLE	£2.44M	11.41	-£21.76M	-£6.76	-1.28

Does the media favor DXRX or AGL?

In the previous week, Diaceutics had 6 more articles in the media than ANGLE. MarketBeat recorded 6 mentions for Diaceutics and 0 mentions for ANGLE. Diaceutics' average media sentiment score of 1.09 beat ANGLE's score of 0.00 indicating that Diaceutics is being referred to more favorably in the media.

Company	Overall Sentiment
Diaceutics	Positive
ANGLE	Neutral

Which has more volatility and risk, DXRX or AGL?

Diaceutics has a beta of 0.58, indicating that its share price is 42% less volatile than the S&P 500. Comparatively, ANGLE has a beta of 0.22, indicating that its share price is 78% less volatile than the S&P 500.

Summary

Diaceutics beats ANGLE on 13 of the 17 factors compared between the two stocks.